Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/151863
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hox, Valerie | - |
dc.contributor.author | Lourijsen, Evelijn | - |
dc.contributor.author | Jordens, Arnout | - |
dc.contributor.author | Aasbjerg, Kristian | - |
dc.contributor.author | Agache, Ioana | - |
dc.contributor.author | Alobid, Isam | - |
dc.contributor.author | Bachert, Claus | - |
dc.contributor.author | Boussery, Koen | - |
dc.contributor.author | Campo, Paloma | - |
dc.contributor.author | Fokkens, Wytske | - |
dc.contributor.author | Hellings, Peter | - |
dc.contributor.author | Hopkins, Claire | - |
dc.contributor.author | Klimek, Ludger | - |
dc.contributor.author | Mäkelä, Mika | - |
dc.contributor.author | Mösges, Ralph | - |
dc.contributor.author | Mullol i Miret, Joaquim | - |
dc.contributor.author | Pujols Tarrés, Laura | - |
dc.contributor.author | Rondon, Carmen | - |
dc.contributor.author | Rudenko, Michael | - |
dc.contributor.author | Toppila‑Salmi, Sanna | - |
dc.contributor.author | Scadding, Glenis | - |
dc.contributor.author | Scheire, Sophie | - |
dc.contributor.author | Tomazic, Peter‑Valentin | - |
dc.contributor.author | Van Zele, Thibaut | - |
dc.contributor.author | Wagemann, Martin | - |
dc.contributor.author | van Boven, Job F. M. | - |
dc.contributor.author | Gevaert, Philippe | - |
dc.date.accessioned | 2020-03-03T23:46:07Z | - |
dc.date.available | 2020-03-03T23:46:07Z | - |
dc.date.issued | 2020-01-03 | - |
dc.identifier.issn | 2045-7022 | - |
dc.identifier.uri | http://hdl.handle.net/2445/151863 | - |
dc.description.abstract | Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that - potentially severe - side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease. | - |
dc.format.extent | 27 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | BioMed Central | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1186/s13601-019-0303-6 | - |
dc.relation.ispartof | Clinical and Translational Allergy, 2020, vol. 10 | - |
dc.relation.uri | https://doi.org/10.1186/s13601-019-0303-6 | - |
dc.rights | cc by (c) Hox et al., 2020 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | - |
dc.source | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) | - |
dc.subject.classification | Rinitis | - |
dc.subject.classification | Glucocorticoides | - |
dc.subject.other | Rhinitis | - |
dc.subject.other | Glucocorticoids | - |
dc.title | Benefits and harm of systemic steroids for short- And long-term use in rhinitis and rhinosinusitis: an EAACI position paper | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2020-02-27T11:03:32Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.idimarina | 6016514 | - |
dc.identifier.pmid | 31908763 | - |
Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
12474_6016514_13601_2019_article_303.pdf | 1.17 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License